Onkologie. 2012:6(2):104-106

Patient with neuroendocrine tumor of the lung

Hana Honová
Onkologická klinika VFN a 1. LF UK, Praha

We describe case history of 25 years old woman with pulmonary form of neuroendocrine tumor. There was overproduction of ACTH

(adenocorticotropic hormon) resulting in Cushings syndrome. After the surgery we detected residual tumor in mediastinum with relapsing

hormonal symptoms. Therefore we started the systemic treatment with somatostatin analogs. The disease became resistant after

3 years and therefore was the patient indicated for bilateral adrenalectomy. Despite of very good clinical outcome the primary tumor

remains in mediastinum and the further treatment remains problematic.

Keywords: neuroendocrine tumors, somatostatin analogs, treatment options

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Honová H. Patient with neuroendocrine tumor of the lung. Onkologie. 2012;6(2):104-106.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Yao JC, et al. One hundred years after, ,carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072. Go to original source... Go to PubMed...
    2. Oberg K, Jelic S. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow up. ANN Oncol 2008; 19(Suppl. 2): 104-105. Go to original source... Go to PubMed...
    3. Eriksson B, Skogseid B, Lundqvist G, et al. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990; 65(9): 1883-1890. Go to original source...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.